Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 5.331B
March 31, 2026 4.960B
December 31, 2025 4.568B
September 30, 2025 4.170B
June 30, 2025 3.765B
March 31, 2025 3.404B
December 31, 2024 3.083B
September 30, 2024 2.656B
June 30, 2024 2.540B
March 31, 2024 2.251B
December 31, 2023 1.995B
September 30, 2023 1.778B
June 30, 2023 1.425B
March 31, 2023 1.201B
December 31, 2022 1.080B
September 30, 2022 944.24M
June 30, 2022 792.39M
March 31, 2022 640.54M
December 31, 2021 978.16M
September 30, 2021 896.12M
June 30, 2021 798.68M
March 31, 2021 739.82M
Date Value
December 31, 2020 206.43M
September 30, 2020 166.66M
June 30, 2020 131.06M
March 31, 2020 309.41M
December 31, 2019 338.40M
September 30, 2019 353.42M
June 30, 2019 370.50M
March 31, 2019 192.96M
December 31, 2018 159.62M
September 30, 2018 126.44M
June 30, 2018 300.31M
March 31, 2018 255.51M
December 31, 2017 228.82M
September 30, 2017 215.09M
June 30, 2017 -2.382M
March 31, 2017 -1.842M
December 31, 2016 -0.978M
September 30, 2016 -0.505M
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Basilea Pharmaceutica AG 273.32M
Santhera Pharmaceuticals Holding AG 51.47M
AC Immune SA 0.00
CRISPR Therapeutics AG -202.31M
Idorsia Ltd. 189.17M